Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: AMPH stock price vs WLY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WLY's multiple
Needs WLY P/E.
Implied fair value · at AMPH's multiple
Needs AMPH P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AMPH FY 2025 (ended Dec 31, 2025) · WLY FY 2026 (ended Apr 30, 2026). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Amphastar Pharmaceuticals, Inc. · implied price per share
Bear
$44.56
Base
$52.42
Bull
$60.29
JOHN WILEY & SONS, INC. · implied price per share
Bear
$47.39
Base
$55.75
Bull
$64.12
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.06x
0.82x
Net debt / EBITDA
Leverage against operating earnings
-0.99x
1.25x
Cash and equivalents
Liquid reserves on the balance sheet
$282.81M
$75.62M
Total debt
Interest-bearing obligations outstanding
$43.70M
$695.90M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BRISTOL MYERS SQUIBB CO
AMPH vs BMY
TEVA PHARMACEUTICAL INDUSTRIES LTD
AMPH vs TEVA
Bausch Health Companies Inc.
AMPH vs BHC
PERRIGO Co plc
AMPH vs PRGO
ANI PHARMACEUTICALS INC
AMPH vs ANIP
NEWS CORP
AMPH vs NWSA
NEW YORK TIMES CO
AMPH vs NYT
Barnes & Noble Education, Inc.
AMPH vs BNED
RELX PLC
AMPH vs RELX
SCHOLASTIC CORP
AMPH vs SCHL
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
